Imricor Medical Systems Inc. Q3 2026 Financial Results
Key points
- Net loss of $2.9 million for Q3 2026
- Revenue increased to $187.8 million for Q3 2026
- Total assets at $69.3 million as of September 30, 2026
Full summary
Imricor Medical Systems, Inc. reported its financial results for the third quarter of 2026. The company posted a net loss of $2.9 million for the quarter, compared to a net loss of $3.5 million in the same period last year. Revenue increased to $187.8 million for Q3 2026, up from $34.8 million in Q3 2025. The company's total assets were $69.3 million as of September 30, 2026, with cash and cash equivalents amounting to $62.1 million. The company's financial statements are prepared in accordance with U.S. GAAP and include the accounts of Imricor Medical Systems, Inc. and its wholly-owned subsidiary, Imricor B.V.
Summary generated by a large language model. Please interpret with care.